Mariko Kawakami Selected Research

Mariko Kawakami Research Topics

Disease

25	Neoplasms (Cancer) 01/2015 - 01/2002
10	Squamous Cell Carcinoma of Head and Neck 01/2016 - 12/2003
6	Head and Neck Neoplasms (Head and Neck Cancer) 04/2007 - 02/2002
5	Glioblastoma (Glioblastoma Multiforme) 09/2005 - 10/2002
5	Glioma (Gliomas) 05/2005 - 10/2002
4	Carcinoma (Carcinomatosis) 03/2008 - 03/2003
4	Brain Neoplasms (Brain Tumor) 05/2005 - 01/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2009 - 12/2007
2	Ovarian Neoplasms (Ovarian Cancer) 09/2006 - 09/2005
2	Breast Neoplasms (Breast Cancer) 02/2004 - 05/2003
1	Cachexia 09/2006
1	Polyps 09/2006
1	Melanoma (Melanoma, Malignant) 04/2006
1	Neoplasm Metastasis (Metastasis) 09/2005
1	Lymphatic Metastasis 05/2005
1	Hodgkin Disease (Hodgkin's Disease) 05/2005
1	Diabetes Mellitus 12/2004
1	Kaposi Sarcoma (Kaposi's Sarcoma) 08/2004
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2004
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2003
1	Prostatic Neoplasms (Prostate Cancer) 03/2003
1	Lung Neoplasms (Lung Cancer) 11/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

22	Cytotoxins (Cytolysins)IBA 09/2006 - 01/2002
13	Interleukin-13IBA 09/2006 - 02/2002
10	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 09/2006 - 02/2002
7	Interleukin-4 (Interleukin 4)IBA 09/2005 - 01/2002
7	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 09/2005 - 01/2002
7	ExotoxinsIBA 09/2004 - 02/2002
4	Proteins (Proteins, Gene)FDA Link 05/2005 - 01/2002
3	Cisplatin (Platino)FDA LinkGeneric 09/2010 - 08/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2007 - 02/2006
3	Interleukin-13 Receptor alpha2 SubunitIBA 09/2006 - 12/2003
3	IL13-PE38IBA 05/2005 - 02/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2004 - 10/2002
3	Recombinant Fusion ProteinsIBA 08/2004 - 05/2003
3	InterleukinsIBA 05/2003 - 07/2002
2	vandetanib (ZD6474)IBA 01/2016 - 02/2007
2	Therapeutic UsesIBA 03/2008 - 08/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2007 - 02/2006
2	CreatinineIBA 04/2007 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 09/2006 - 10/2002
2	Cytokine Receptors (Cytokine Receptor)IBA 05/2005 - 08/2002
2	Messenger RNA (mRNA)IBA 09/2004 - 03/2003
2	Pseudomonas aeruginosa Exotoxin AIBA 09/2004 - 02/2004
2	interleukin-4-Pseudomonas exotoxinIBA 10/2003 - 07/2002
2	Carrier Proteins (Binding Protein)IBA 05/2003 - 08/2002
2	Caspase 3 (Caspase-3)IBA 01/2003 - 10/2002
1	Photosensitizing Agents (Photosensitizers)IBA 01/2015
1	protoporphyrin IXIBA 01/2015
1	AcidsIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	Leucovorin (Folinic Acid)FDA Link 09/2010
1	Fluorouracil (Carac)FDA LinkGeneric 09/2010
1	Docetaxel (Taxotere)FDA Link 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 09/2010
1	Monoclonal AntibodiesIBA 07/2007
1	Bevacizumab (Avastin)FDA Link 07/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2007
1	DNA VaccinesIBA 04/2006
1	AntigensIBA 04/2006
1	Chemokine CXCL9IBA 04/2006
1	Taxoids (Taxanes)IBA 02/2006
1	Interleukin-8 (Interleukin 8)IBA 02/2006
1	Antineoplastic Agents (Antineoplastics)IBA 02/2006
1	Complementary DNA (cDNA)IBA 05/2005
1	CytokinesIBA 05/2005
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 08/2004
1	Interleukin-13 Receptor alpha1 SubunitIBA 12/2003
1	LigandsIBA 10/2003
1	AndrogensIBA 03/2003
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2002
1	CaspasesIBA 10/2002
1	Cytochromes c (Cytochrome c)IBA 10/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2002
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2002
1	InterferonsIBA 08/2002
1	Indicators and Reagents (Reagents)IBA 08/2002
1	DNA (Deoxyribonucleic Acid)IBA 02/2002
1	Interleukin-4 Receptor alpha SubunitIBA 01/2002

Therapy/Procedure

15	Therapeutics 09/2006 - 01/2002
6	Chemoradiotherapy 09/2010 - 12/2007
3	Aftercare (After-Treatment) 02/2006 - 02/2002
3	Injections 12/2004 - 07/2002
2	Radiotherapy 10/2009 - 02/2009
1	Drug Therapy (Chemotherapy) 10/2009
1	Laryngectomy 12/2007
1	Laryngoscopes 09/2006
1	Oral Administration 02/2006
1	Immunotherapy 02/2002